dc.contributor.author | Karabaş, Merve | |
dc.contributor.author | Tepe, Nermin | |
dc.contributor.author | Esmeli, Figen | |
dc.date.accessioned | 2024-05-30T06:06:08Z | |
dc.date.available | 2024-05-30T06:06:08Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.issn | 1590-1874 / 1590-3478 | |
dc.identifier.uri | https://doi.org/10.1007/s10072-023-07075-2 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12462/14761 | |
dc.description.abstract | Özet bilgisi yok. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Springer-Verlag Italia S.R.L. | en_US |
dc.relation.isversionof | 10.1007/s10072-023-07075-2 | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Clinical Neurology | en_US |
dc.subject | Neurosciences | en_US |
dc.title | Development of malignant melanoma and squamous cell carcinoma in a patient receiving fingolimod treatment | en_US |
dc.type | letter | en_US |
dc.relation.journal | Neurological Sciences | en_US |
dc.contributor.department | Tıp Fakültesi | en_US |
dc.contributor.authorID | 0000-0003-4148-2539 | en_US |
dc.contributor.authorID | 0000-0002-7129-948X | en_US |
dc.identifier.volume | 45 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 359 | en_US |
dc.identifier.endpage | 360 | en_US |
dc.relation.publicationcategory | Diğer | en_US |